EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Role of ligandin as a binding protein and as an enzyme in the biliary excretion of sulfobromophthalein


Journal of Pharmacology and Experimental Therapeutics 221(1): 242-246
Role of ligandin as a binding protein and as an enzyme in the biliary excretion of sulfobromophthalein
The effect of butylated hydroxyanisole (BHA; 600 mg/kg i.p. daily, for 10 days) and trans-stilbene oxide (TSO; 400 mg/kg i.p. daily, for 4 days) on the in vitro hepatic activity of glutathione transferases, the hepatic content of organic anion binding proteins and the plasma disappearance and biliary excretion of sulfobromophthalein (BSP), phenol-3,6-dibromsulphthalein disulfonate and [3H]ouabain was investigated in mice (BHA) and rats (TSO). Both BHA and TSO increased glutathione transferase activity toward BSP (360 and 200%), hepatic ligandin content (160 and 120%) and the biliary excretion of BSP (370 and 85%). BSP-glutathione excretion was enhanced, indicating that BSP conjugation was also stimulated in vivo. In contrast to BSP, biliary excretion of phenol-3,6-dibromsulphthalein disulfonate and organic anion which is not biotransformed but binds to ligandin, was unaltered or slightly increased (29%) after BHA or TSO treatment, respectively. TSO administration also did not affect the excretion of ouabain, a compound that neither binds to ligandin nor is biotransformed before excretion. Induction of ligandin failed to influence the initial disappearance of BSP, phenol-3,6-dibromsulphthalein disulfonate or ouabain from plasma, suggesting that induction had no marked effect on the hepatic uptake of these compounds. These studies suggest that ligandin plays a more important role in the biliary excretion of BSP due to its enzymatic rather than its binding properties.

(PDF 0-2 workdays service: $29.90)

Accession: 006351404

PMID: 7062286



Related references

Inhibition of the enzymatic activity of ligandin by organogermanium, organolead or organotin compounds and the biliary excretion of sulfobromophthalein by the rat. Journal of Pharmacology and Experimental Therapeutics 208(2): 248-253, 1979

Increase in the biliary excretion of drugs by microsomal enzyme inducers role of ligandin. INT UNION PHARMACOL PROCEEDINGS OF THE INTERNATIONAL CONGRESS OF PHARMACOLOGY, 6TH ABSTRACT HELSINKI, FINLAND, 1975 632p ILLUS PERGAMON PRESS: OXFORD, ENGL ; NEW YORK, N Y , USA ISBN 0-08-021308-1 641, 1977

Biliary excretion of drugs: role of ligandin in newborn immaturity and in the action of microsomal enzyme inducers. Journal of Pharmacology and Experimental Therapeutics 195(2): 311-319, 1975

Plasma disappearance and biliary excretion of sulfobromophthalein and phenol-3,6-dibromphthalein disulfonate after microsomal enzyme induction. Biochemical Pharmacology 19(4): 1241-1249, 1970

Biliary excretion of sulfobromophthalein compounds in normal and mutant Corriedale sheep. Evidence for a disproportionate transport defect for conjugated sulfobromophthalein. Hepatology 1(5): 441-447, 1981

Biliary cefpiramide excretion: its relation to biliary excretion of bile acids and sulfobromophthalein. Pharmacology 51(1): 24-32, 1995

Role of glutathione and methylation in the biliary excretion of selenium. The paradoxical effect of sulfobromophthalein. Biochemical Pharmacology 56(10): 1381-1389, 1998

Effect of arsenicals on biliary excretion of endogenous non-protein thiols, mercurials and sulfobromophthalein. Archives of Toxicology. Supplement. 13: 340-342, 1989

Biliary excretion of conjugated sulfobromophthalein sodium (BSP) in rats fed a protein-free diet. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 132(2): 704-707, 1969

Role of biotransforma-tion, biliary excretion and circulatory changes in chlorpromazine -induced sulfobromophthalein retention. Jour Pharmacol And Exptl Therap 139(3): 383-389, 1963